A citation-based method for searching scientific literature

Satoshi Deyama, Ronald S Duman. Pharmacol Biochem Behav 2020
Times Cited: 75







List of co-cited articles
739 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
Aline Santos Monte, Greicy Coelho de Souza, Roger S McIntyre, Joanna K Soczynska, Júnia Vieira dos Santos, Rafaela Carneiro Cordeiro, Bruna Mara Machado Ribeiro, David Freitas de Lucena, Silvânia Maria Mendes Vasconcelos, Francisca Cléa Florenço de Sousa,[...]. J Psychopharmacol 2013
79
1


Hallucinogenic drug abuse: manifestations and management.
L P Solursh, W R Clement. Can Med Assoc J 1968
20
5

A systematic review of the indirect costs of schizophrenia in Europe.
A Fasseeh, B Németh, A Molnár, F-U Fricke, M Horváth, K Kóczián, Á Götze, Z Kaló. Eur J Public Health 2018
16
6


Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.
S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, O A Andreassen, C Arango, N Banaj, S Bouix,[...]. Mol Psychiatry 2018
344
1


Cortical thinning in temporo-parietal junction (TPJ) in non-affective first-episode of psychosis patients with persistent negative symptoms.
Michael Bodnar, Cindy L Hovington, Lisa Buchy, Ashok K Malla, Ridha Joober, Martin Lepage. PLoS One 2014
35
2


Cortical thinning in cingulate and occipital cortices in first episode schizophrenia.
Katherine L Narr, Arthur W Toga, Philip Szeszko, Paul M Thompson, Roger P Woods, Delbert Robinson, Serge Sevy, YungPing Wang, Karen Schrock, Robert M Bilder. Biol Psychiatry 2005
163
1

Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in the rat cerebral cortex.
E Ampuero, F J Rubio, R Falcon, M Sandoval, G Diaz-Veliz, R E Gonzalez, N Earle, A Dagnino-Subiabre, F Aboitiz, F Orrego,[...]. Neuroscience 2010
102
1

Hippocampal Pathology in Clinical High-Risk Patients and the Onset of Schizophrenia.
Frank A Provenzano, Jia Guo, Melanie M Wall, Xinyang Feng, Hannah C Sigmon, Gary Brucato, Michael B First, Douglas L Rothman, Ragy R Girgis, Jeffrey A Lieberman,[...]. Biol Psychiatry 2020
31
3

Behavioral phenotypes of Disc1 missense mutations in mice.
Steven J Clapcote, Tatiana V Lipina, J Kirsty Millar, Shaun Mackie, Sheila Christie, Fumiaki Ogawa, Jason P Lerch, Keith Trimble, Masashi Uchiyama, Yoshiyuki Sakuraba,[...]. Neuron 2007
407
1



Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use.
Charles P Taylor, Stephen F Traynelis, Joao Siffert, Laura E Pope, Rae R Matsumoto. Pharmacol Ther 2016
81
1

Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial.
Herriot Tabuteau, Amanda Jones, Ashley Anderson, Mark Jacobson, Dan V Iosifescu. Am J Psychiatry 2022
14
7

The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.
Maryia Zhdanava, Dominic Pilon, Isabelle Ghelerter, Wing Chow, Kruti Joshi, Patrick Lefebvre, John J Sheehan. J Clin Psychiatry 2021
38
2

Efficacy of dextromethorphan for the treatment of depression: a systematic review of preclinical and clinical trials.
Amna Majeed, Jiaqi Xiong, Kayla M Teopiz, Jason Ng, Roger Ho, Joshua D Rosenblat, Lee Phan, Bing Cao, Roger S McIntyre. Expert Opin Emerg Drugs 2021
10
10

Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI).
Dan V Iosifescu, Amanda Jones, Cedric O'Gorman, Caroline Streicher, Samantha Feliz, Maurizio Fava, Herriot Tabuteau. J Clin Psychiatry 2022
7
14


Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.
Saurabh S Kokane, Ross J Armant, Carlos A Bolaños-Guzmán, Linda I Perrotti. Behav Brain Res 2020
22
4

Glutamate receptors and synaptic plasticity: The impact of Evans and Watkins.
G L Collingridge, W C Abraham. Neuropharmacology 2022
9
11


Differential brain, but not serum VEGF levels in a genetic rat model of depression.
Betina Elfving, Pia Høgh Plougmann, Gregers Wegener. Neurosci Lett 2010
45
2

Labelling and optical erasure of synaptic memory traces in the motor cortex.
Akiko Hayashi-Takagi, Sho Yagishita, Mayumi Nakamura, Fukutoshi Shirai, Yi I Wu, Amanda L Loshbaugh, Brian Kuhlman, Klaus M Hahn, Haruo Kasai. Nature 2015
365
1


Transforming growth factor-beta signalling in brain disorders.
Denis Vivien, Carine Ali. Cytokine Growth Factor Rev 2006
93
1

The mood-improving actions of antidepressants do not depend on neurogenesis but are associated with neuronal remodeling.
J M Bessa, D Ferreira, I Melo, F Marques, J J Cerqueira, J A Palha, O F X Almeida, N Sousa. Mol Psychiatry 2009
430
1

VEGF in the nervous system.
Jeffrey M Rosenstein, Janette M Krum, Christiana Ruhrberg. Organogenesis 2010
194
1

Electroconvulsive seizure and VEGF increase the proliferation of neural stem-like cells in rat hippocampus.
Eri Segi-Nishida, Jennifer L Warner-Schmidt, Ronald S Duman. Proc Natl Acad Sci U S A 2008
174
1

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.
A B Kulkarni, C G Huh, D Becker, A Geiser, M Lyght, K C Flanders, A B Roberts, M B Sporn, J M Ward, S Karlsson. Proc Natl Acad Sci U S A 1993
1

Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex.
Kristy R Howell, Ammar Kutiyanawalla, Anilkumar Pillai. PLoS One 2011
55
1

Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells.
Katsuya Nakamura, Kelly C Martin, Jennifer K Jackson, Kiichiro Beppu, Chan-Wook Woo, Carol J Thiele. Cancer Res 2006
170
1

VEGF links hippocampal activity with neurogenesis, learning and memory.
Lei Cao, Xiangyang Jiao, David S Zuzga, Yuhong Liu, Dahna M Fong, Deborah Young, Matthew J During. Nat Genet 2004
615
1

Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.
R Musil, M J Schwarz, M Riedel, S Dehning, A Cerovecki, I Spellmann, V Arolt, N Müller. J Affect Disord 2011
77
1

A role for MAP kinase signaling in behavioral models of depression and antidepressant treatment.
Catharine H Duman, Lee Schlesinger, Masafumi Kodama, David S Russell, Ronald S Duman. Biol Psychiatry 2007
264
1

A key role of miR-132-5p in the prefrontal cortex for persistent prophylactic actions of (R)-ketamine in mice.
Li Ma, Long Wang, Lijia Chang, Jiajing Shan, Youge Qu, Xingming Wang, Xiayun Wan, Yuko Fujita, Kenji Hashimoto. Transl Psychiatry 2022
3
33

Alteration of immune markers in a group of melancholic depressed patients and their response to electroconvulsive therapy.
Gavin Rush, Aoife O'Donovan, Laura Nagle, Catherine Conway, AnnMaria McCrohan, Cliona O'Farrelly, James V Lucey, Kevin M Malone. J Affect Disord 2016
45
2

Xiaoyaosan ethyl acetate fraction alleviates depression-like behaviors in CUMS mice by promoting hippocampal neurogenesis via modulating the IGF-1Rβ/PI3K/Akt signaling pathway.
Jiuseng Zeng, Yafei Ji, Fei Luan, Jingwen Hu, Yixing Rui, Yao Liu, Zhili Rao, Rong Liu, Nan Zeng. J Ethnopharmacol 2022
4
25

Antidepressant effects of acupoint stimulation and fluoxetine by increasing dendritic arborization and spine density in CA1 hippocampal neurons of socially isolated rats.
Amalia Dávila-Hernández, Sergio R Zamudio, Lucía Martínez-Mota, Roberto González-González, Eduardo Ramírez-San Juan. Neurosci Lett 2018
11
9


Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.
Li Qian, Sung-Jen Wei, Dan Zhang, Xiaoming Hu, Zongli Xu, Belinda Wilson, Jamel El-Benna, Jau-Shyong Hong, Patrick M Flood. J Immunol 2008
106
1

Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression.
Vivi M Heine, Jessica Zareno, Suharti Maslam, Marian Joëls, Paul J Lucassen. Eur J Neurosci 2005
154
1


Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression.
Maura Boldrini, Adrienne N Santiago, René Hen, Andrew J Dwork, Gorazd B Rosoklija, Hadassah Tamir, Victoria Arango, J John Mann. Neuropsychopharmacology 2013
209
1

Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice.
Pawel Lisowski, Grzegorz R Juszczak, Joanna Goscik, Adrian M Stankiewicz, Marek Wieczorek, Lech Zwierzchowski, Artur H Swiergiel. BMC Neurosci 2013
25
4

Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress.
Yan-Wei Luo, Yang Xu, Wen-Yu Cao, Xiao-Lin Zhong, Juan Duan, Xue-Qin Wang, Zhao-Lan Hu, Fang Li, Jian-Yi Zhang, Ming Zhou,[...]. Neuropharmacology 2015
47
2

The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers.
Lori M Hilt, Lisa C Sander, Susan Nolen-Hoeksema, Arthur A Simen. Neurosci Lett 2007
57
1

Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition.
Steven F Grieco, Yuyan Cheng, Hagit Eldar-Finkelman, Richard S Jope, Eléonore Beurel. Prog Neuropsychopharmacol Biol Psychiatry 2017
11
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.